# OnCo record evergreen-theragnostics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/evergreen-theragnostics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "evergreen-theragnostics" ;
  schema:name "Evergreen Theragnostics"@en ;
  schema:description "Evergreen Theragnostics manufactures radioactive cancer medicines for other companies and develops its own imaging agent for neuroendocrine tumours and a treatment for small cell lung cancer. Lantheus agreed to buy it in 2025."@en ;
  schema:url <https://onco.cc/companies/evergreen-theragnostics/>, <https://www.evergreentgn.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.evergreentgn.com/>, <https://www.evergreentgn.com/2025/01/28/lantheus-to-acquire-evergreen-theragnostics-for-upfront-payment-of-250-million-to-drive-strategic-evolution-into-fully-integrated-radiopharmaceutical-leader/>, <https://www.evergreentgn.com/news/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/sclc/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/pet/> .